1. 2134. A Phase 2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster Dose of a Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine (GBS6). (15th December 2022) Authors: Jongihlati, Babalwa; Segall, Nathan; Block, Stanley; Peterson, James; Absalon, Judith; Munson, Samantha; Sanchez-Pearson, Yasmin; Simon, Raphael; de Monerri, Natalie Silmon; Radley, David; Gomme, Emily A; Gaylord, Michelle; Gruber, William C; Jansen, Kathrin U; Scott, Daniel A; Anderson, Annaliesa S Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗